In metabolic disease states such as obesity and diabetes, circulating nonesterified fatty acids (NEFAs) rise due to insulin resistance or increased adipose lipolysis, driving enhanced FA uptake into cardiomyocytes via transporters such as CD36 [53, 54, 76]. This evidence concerns the gene INS and obesity disorder.